期刊
FRONTIERS IN PHARMACOLOGY
卷 12, 期 -, 页码 -出版社
FRONTIERS MEDIA SA
DOI: 10.3389/fphar.2021.748149
关键词
autophagy; natural compound; pathway; cancer therapy; small-molecule drug
资金
- Department of Science and Technology of Sichuan Province [2021YFS0009]
- Chinese National Natural Science Foundation [82071168]
- Research Foundation for Administration of traditional Chinese Medicine of Sichuan Province [2020HJZX002]
Natural products have been shown to have therapeutic benefits for cancer therapy by modulating key autophagic signaling pathways, providing inspiration for the discovery of novel small-molecule drugs. Some representative natural compounds, such as curcumin and resveratrol, have displayed therapeutic effects in different types of human cancers through the regulation of autophagy pathways. These findings suggest the potential for exploring more natural compounds as candidate drugs for future cancer therapy targeting autophagy pathways.
Natural products are well-characterized to have pharmacological or biological activities that can be of therapeutic benefits for cancer therapy, which also provide an important source of inspiration for discovery of potential novel small-molecule drugs. In the past three decades, accumulating evidence has revealed that natural products can modulate a series of key autophagic signaling pathways and display therapeutic effects in different types of human cancers. In this review, we focus on summarizing some representative natural active compounds, mainly including curcumin, resveratrol, paclitaxel, Bufalin, and Ursolic acid that may ultimately trigger cancer cell death through the regulation of some key autophagic signaling pathways, such as RAS-RAF-MEK-ERK, PI3K-AKT-mTOR, AMPK, ULK1, Beclin-1, Atg5 and p53. Taken together, these inspiring findings would shed light on exploiting more natural compounds as candidate small-molecule drugs, by targeting the crucial pathways of autophagy for the future cancer therapy.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据